BackNovo Nordisk A/S Class B Overview

Novo Nordisk A/S Class B Other Current Assets

Novo Nordisk A/S Class B's other current assets is $3.9B.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$3.85B
↓ 68.64% YoYΔ $-8.43B vs prior year quarter

Peer average / median

Loading

Novo Nordisk A/S Class B Other Current Assets History

Loading

Novo Nordisk A/S Class B vs. peers: Other Current Assets Comparison

Loading

Novo Nordisk A/S Class B Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Novo Nordisk A/S Class B (NONOF) FAQ

As of the most recent data (June 2026), NONOF shows a other current assets of $3.9B. That compares with $12B in the prior-year period — down 68.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NONOF's other current assets is now $3.9B (was $12B) — a 68.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Nordisk A/S Class B is outperforming or lagging.

Tracking NONOF's other current assets over time shows whether Novo Nordisk A/S Class B is scaling, shrinking, or reshaping that part of the business. The current reading is $3.9B That compares with $12B in the prior-year period — down 68.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Novo Nordisk A/S Class B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $3.9B) with ownership activity and broader fundamentals.

Novo Nordisk A/S Class B's other current assets is $3.9B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.